Real-World Bombshell: Pfizer mRNA Vaccine Fades - Public Forum - IMA Forums

Real-World Bombshell: Pfizer mRNA Vaccine Fades

Public Forum

0.0268249511719 seconds

Real-World Bombshell: Pfizer mRNA Vaccine Fades

Posted by michael-IMA
0.0266909599304 seconds
on July 1, 2024 at 6:44 pm EDT

https://www.trialsitenews.com/a/large-real-world-bombshell-pfizer-mrna-vaccine-fades-no-protection-against-hospitalization-unless-boosted-8a9e28f6

trialsitenews.com
Real-World Bombshell: Pfizer mRNA Vaccine Fades--No Protection Against Hospitalization Even Boosters Fall Short
Are the COVID-19 mRNA vaccines durability improving? No, they are not, and in fact, even if an individual followed public health instructions, getting three doses of the primary series to bolster protection with a mutating virus and a vaccine truly … Continue reading

vflo
0.026670217514 seconds
replied 8 months, 1 week ago 4 Members · 4 Replies
4 Replies

0.0185749530792 seconds

vegandan
0.0181529521942 seconds

Member
July 3, 2024 at 12:45 pm EDT

This cash cow appears to be dead. The new focus is on bird flu vax. The new cash cow. Fool me once!
- 0.0223269462585 seconds
  
  vflo
  0.0207250118256 seconds
  
  Member
  July 3, 2024 at 11:18 pm EDT
  
  Bird Pflu vaccines. How lovely. They’re probably Pfool proof though. The Communist News Network never lies.
- 0.0216028690338 seconds
  
  kate australia
  0.0178968906403 seconds
  
  Member
  July 4, 2024 at 8:29 am EDT
  
  Yep 100%
  - 0.0221290588379 seconds
    
    vflo
    0.0203740596771 seconds
    
    Member
    July 4, 2024 at 10:29 pm EDT
    
    By Jen Christensen, CNN
    
    3 minute read. Published 3:15 PM EDT, Tue July 2, 2024
    
    The US Department of Health and Human Services announced Tuesday a contract with Moderna to develop an mRNA vaccine that targets pandemic flu, in case the shot becomes necessary with the latest outbreak of bird flu.
    
    https://www.cnn.com/2024/07/02/health/moderna-mrna-bird-flu-vaccine/index.html?iid=cnn_buildContentRecirc_end_recirc

Log In to Reply

Log in to reply.